ALK and non-small cell lung carcinoma: Analysis of The Cancer Genome Atlas (TCGA) LUAD dataset via cBioPortal confirms that ALK fusions are largely mutually exclusive with EGFR, KRAS, and ROS1 alterations, underscoring ALK’s role as a distinct and actionable driver in a molecularly defined NSCLC subset [18].